+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neurovirulence for rats of the JHMV variants escaped from neutralization with the S1-specific monoclonal antibodies

Neurovirulence for rats of the JHMV variants escaped from neutralization with the S1-specific monoclonal antibodies

Advances in Experimental Medicine and Biology 380: 185-187

We have studied the neurovirulence for rats of the MAb-resistant variants isolated from a highly neurovirulent JHMV, cl-2. The variants, MM6 and MM13, with point mutation located within the N terminal 100 amino acids (aa) of the S1 protein showed no alteration in neurovirulence in comparison with cl-2, showing high neurovirulence. The variants, MM65 and MM85, with a deletion composed of about 150 aa located in the middle of the S1 subunit were revealed to be non-neurovirulent. A variant MM78 with one aa deletion, asparagic acid at number 543 from the N terminus of the S1, was shown to be low-virulence. The neurovirulence of these viruses paralleled with the viral growth potential in the rat brain. However, all of these variants as well as parental cl-2 showed high neurovirulence for mice. These results suggest that the domain composed of about 150 aa in the middle of the S1 is critical for high-neurovirulence of JHMV for rats.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046786712

Download citation: RISBibTeXText

PMID: 8830478

Related references

Neurovirulence of six different murine coronavirus JHMV variants for rats. Virus Research 20(1): 45-58, 1991

Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV c1-2 variant. Journal of General Virology 74: 1421-1425, 1993

HIV-1 mutants that escaped neutralization by monoclonal antibodies directed against conformational determinants on gp120. Journal of Cellular Biochemistry Suppl. 0(17 Part E): 72, 1993

Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants. Journal of General Virology 69: 451-458, 1988

Localization of neurovirulence determinant for rats on the S1 subunit of murine coronavirus JHMV. Virology 208(1): 67-74, 1995

Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies. Virology 161(2): 429-437, 1987

Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology 162(1): 21-29, 1988

Characterization of JHMV variants isolated from rat brain and cultured neural cells after wild type JHMV infection. Advances in Experimental Medicine and Biology 218: 343-349, 1987

Complement independent neutralization of chlamydia trachomatis infectivity for hamster kidney cells with monoclonal antibodies specific to the major outer membrane protein mechanism of neutralization and antigenic topology of neutralizing epitopes. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 34, 1989

Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor. Molecular Immunology 57(2): 247-254, 2014

Isolation of Neutralizing Monoclonal Antibodies to Human Astrovirus and Characterization of Virus Variants That Escape Neutralization. Journal of Virology 93(2):, 2019

Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. Journal of Virology 61(5): 1726-1730, 1987

Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab. Journal of Infectious Diseases 203(5): 674-682, 2011

Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. Journal of General Virology 67: 2247-2251, 1986

Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera. Infection and Immunity 65(1): 317-319, 1997